Alembic Pharmaceuticals informs about company updates

22 Apr 2019 Evaluate

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Approval for Teriflunomide Tablets, 7 mg and 14 mg; Tobramycin Ophthalmic Solution USP, 0.3%. The Company has enclosed its press releases for both the products seperately.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

841.30 -5.60 (-0.66%)
18-Dec-2025 10:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1753.85
Dr. Reddys Lab 1272.55
Cipla 1500.30
Zydus Lifesciences 916.25
Lupin 2111.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×